RxDoctor Payments DataLook up a doctor →

Tiffany Scarff, MD

Neurology · Jackson, MSNPI 1184810012

Payments from drug & device makers

$28,694in general payments, 2019–2025

Across 900 payments — averaging $31.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$14K
  • AbbVie$1K
  • Novartis$1K
  • SK Life Science, Inc.$891
  • Genentech USA, Inc.$888
  • UCB, Inc.$846
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.73$14,349
AbbVie(2 entities)100$1,390
Novartis77$1,059
SK Life Science, Inc.39$891
Genentech USA, Inc.55$888
UCB, Inc.44$846
Acadia Pharmaceuticals Inc49$744
AstraZeneca(2 entities)34$741
Pfizer48$715
Medtronic(2 entities)32$478
Amgen(2 entities)29$459
Greenwich Biosciences, Inc.14$434
Sanofi21$402
Biogen20$383
Argenx US, Inc.15$314
Lilly USA, LLC21$312
Jazz Pharmaceuticals Inc.15$306
Lundbeck LLC16$299
ANI Pharmaceuticals, Inc.15$267
Sunovion Pharmaceuticals Inc.16$254
Bristol Myers Squibb14$203
Neurocrine Biosciences, Inc.11$179
E.r. Squibb & Sons, L.L.C.13$167
EMD Serono, Inc.11$166
Johnson & Johnson4$161
Catalyst Pharmaceuticals, Inc.8$148
Biohaven Pharmaceutical Holding Company Ltd.9$139
Microtransponder, Inc.1$136
Takeda Pharmaceuticals U.S.A., Inc.7$131
Neurelis, Inc.2$126
Acorda Therapeutics, Inc6$124
Supernus Pharmaceuticals, Inc.8$114
GE HealthCare5$114
Otsuka America Pharmaceutical, Inc.5$113
Livanova USA, Inc.5$101
Mallinckrodt Hospital Products Inc.4$96
Impel Pharmaceuticals Inc.4$86
MDD US Operations, LLC4$84
Avanir Pharmaceuticals, Inc.5$83
Eisai Inc.5$82
Biohaven Pharmaceuticals, Inc.5$75
Sumitomo Pharma America, Inc.3$54
Tanabe Pharma America, Inc.3$51
CSL Behring2$47
Mallinckrodt Enterprises LLC3$44
Sanofi-aventis U.S. LLC2$36
Alnylam Pharmaceuticals Inc.2$32
Merz Pharmaceuticals, LLC1$30
Arbor Pharmaceuticals, Inc.2$25
Amylyx Pharmaceuticals, Inc.1$22
Axsome Therapeutics, Inc.1$22
Merck1$20
Kyowa Kirin, Inc.1$20
Phathom Pharmaceuticals, Inc.1$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$16
Mylan Specialty L.p.1$16
Boston Scientific1$15
Portola Pharmaceuticals, LLC1$15
Idorsia Pharmaceuticals US Inc1$15
Amneal Pharmaceuticals LLC1$12

How this compares

$28,694 in reported general payments places this provider in the 80th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi →

Medicare billing

Part B allowed, 2024
$214,628
Medicare patients
560
Services billed
21,158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Jackson

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →